Association of Single Nucleotide Polymorphisms of IL23R and IL17 with Ulcerative Colitis Risk in a Chinese Han Population

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Yu, Pengli ^a   Shen, Fangcheng ^a   Zhang, Xiaofei ^a   Cao, Risheng ^a   Zhao, Xiaodan ^a   Liu, Pengfei ^b   Tu, Huiming ^c   Yang, Xiaozhong ^d   Shi, Ruihua ^a   Zhang, Hongjie ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b JIANGYIN PEOPLE S HOSPITAL   (China)

^c Soochow University   (China)

^d THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23 RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INTERLEUKIN 17 GENE; INTERLEUKIN 23 RECEPTOR GENE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; COLITIS, ULCERATIVE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-17; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN;

EID: 84866272883     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044380     Document Type: Article

References (50)

1. Head KA, Jurenka JS, (2003) Inflammatory bowel disease Part 1: ulcerative colitis-pathophysiology and conventional and alternative treatment options. Altern Med Rev 8: 247-83.
2. Cho JH, (2008) The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8: 458-66.
3. Bouma G, Strober W, (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3: 521-33.
4. Lees CW, Barrett JC, Parkes M, Satsangi J, (2011) New IBD genetics: common pathways with other diseases. Gut 60: 1739-53.
5. Schmechel S, Konrad A, Diegelmann J, Glas J, Wetzke M, et al. (2008) Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status. Inflamm Bowel Dis. 14: 204-12.
6. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, et al. (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39: 207-11.
7. Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, et al. (2009) Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 41: 216-20.
8. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, et al. (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43: 246-52.
9. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, et al. (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 42: 1118-25.
10. Abraham C, Cho J, (2009) Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis 15: 1090-100.
11. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, et al. (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198: 1951-7.
12. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233-40.
13. Bailey SL, Schreiner B, McMahon EJ, Miller SD, (2007) CNS myeloid DCs presenting endogenous myelin peptides' preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. Nat Immunol 8: 172e80.
14. Schmidt-Weber CB, Akdis M, Akdis CA, (2007) TH17 cells in the big picture of immunology. J Allergy Clin Immunol 120: 247e54.
15. Lappalainen M, Halme L, Turunen U, Saavalainen P, Einarsdottir E, et al. (2008) Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population. Inflamm Bowel Dis 14: 1118-24.
16. Einarsdottir E, Koskinen LL, Dukes E, Kainu K, Suomela S, et al. (2009) IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. BMC Med Genet 10: 8.
17. Magyaril L, Melegh B, (2009) Susceptibility genetic variants in Hungarian morbus Crohn and ulcerative colitis patients. Orv Hetil 150: 81-8.
18. Kim SW, Kim ES, Moon CM, Park JJ, Kim TI, et al. (2011) Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease. Gut 60: 1527-36.
19. Wang JY, Shyur SD, Wang WH, Liou YH, Lin CG, et al. (2009) The polymorphisms of interleukin 17A (IL17A) gene and its association with pediatric asthma in Taiwanese population. Allergy 64: 1056-60.
20. Ramsey CD, Lazarus R, Camargo CA Jr, Weiss ST, Celedón JC, (2005) Polymorphisms in the interleukin 17F gene (IL17F) and asthma. Genes Immun 6: 236-41.
21. Nordang GB, Viken MK, Hollis-Moffatt JE, Merriman TR, Førre ØT, et al. (2009) Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand. Rheumatology (Oxford) 48: 367-70.
22. Furuya T, Hakoda M, Ichikawa N, Higami K, Nanke Y, et al. (2007) Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis. Clin Rheumatol 26: 2137-41.
23. Sakamoto J, Munakata A, (2005) The concept, criteria for diagnosis, and disease classification of ulcerative coliti. Nihon Rinsho 63: 744-9.
24. Satsangi J, Silverberg MS, Vermeire S, Colombel JF, (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55: 749-53.
25. Lewis JD, Chuai S, Nessel L, Lichtenstein GR, Aberra FN, et al. (2008) Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis 14: 1660-6.
26. Sarra M, Pallone F, Macdonald TT, Monteleone G, (2010) IL-23/IL-17 axis in IBD. Inflamm Bowel Dis 16: 1808-13.
27. Liu ZJ, Yadav PK, Su JL, Wang JS, Fei K, (2009) Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 14 15: 5784-8.
28. Hundorfean G, Neurath MF, Mudter J, (2012) Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease. Inflamm Bowel Dis 18: 180-6.
29. Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, et al. (2007) IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37: 2695-706.
30. Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, et al. (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116: 1310-6.
31. Duvallet E, Semerano L, Assier E, Falgarone G, Boissier MC, (2011) Interleukin-23: A key cytokine in inflammatory diseases. Ann Med 43: 503-511.
32. Dambacher J, Beigel F, Zitzmann K, De Toni EN, Göke B, et al. (2009) The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut 58: 1207-17.
33. Shen W, Durum SK, (2010) Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease. Neurochem Res 35: 940-6.
34. Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, et al. (2008) IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118: 534-44.
35. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, et al. (2006) IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 290: G827-38.
36. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-3.
37. Jürgens M, Laubender RP, Hartl F, Weidinger M, Seiderer J, et al. (2010) Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis. Am J Gastroenterol 105: 1811-9.
38. Ferguson LR, Han DY, Fraser AG, Huebner C, Lam WJ, et al. (2010) IL23R and IL12B SNPs and Haplotypes Strongly Associate with Crohn's Disease Risk in a New Zealand Population. Gastroenterol Res Pract 2010: 539461.
39. Lacher M, Schroepf S, Helmbrecht J, von Schweinitz D, Ballauff A, et al. (2010) Association of the interleukin-23 receptor gene variant rs11209026 with Crohn's disease in German children. Acta Paediatr 99: 727-33.
40. Lakatos PL, Szamosi T, Szilvasi A, Molnar E, Lakatos L, et al. (2008) ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients. Dig Liver Dis 40: 867-73.
41. Pidasheva S, Trifari S, Phillips A, Hackney JA, Ma Y, et al. (2011) Functional Studies on the IBD Susceptibility Gene IL23R Implicate Reduced Receptor Function in the Protective Genetic Variant R381Q. PLoS One 6: e25038.
42. Huber AK, Jacobson EM, Jazdzewski K, Concepcion ES, Tomer Y, (2008) Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab 93: 1077-81.
43. Hazlett J, Stamp LK, Merriman T, Highton J, Hessian PA (2011) IL-23R rs11209026 polymorphism modulates IL-17A expression in patients with rheumatoid arthritis. Genes Immun [Epub ahead of print].
44. Roberts RL, Gearry RB, Hollis-Moffatt JE, Miller AL, et al. (2007) IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Am J Gastroenterol 102: 2754-61.
45. Oliver J, Rueda B, López-Nevot MA, Gómez-García M, Martín J (2007) Replication of an association between IL23R gene polymorphism with inflammatory bowel disease. Clin Gastroenterol Hepatol 5: 977-81, 981.e1-2.
46. Büning C, Schmidt HH, Molnar T, De Jong DJ, Fiedler T, et al. (2007) Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis. Aliment Pharmacol Ther 26: 1025-33.
47. Glas J, Seiderer J, Wetzke M, Konrad A, Török HP, et al. (2007) rs1004819 is the Main Disease-Associated IL23R Variant in German Crohn's Disease Patients: Combined Analysis of IL23R, CARD15, and OCTN1/2 Variants. PLoS One 2: e819.
48. Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, et al. (2008) The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol 28: 44-9.
49. McGovern DP, Rotter JI, Mei L, Haritunians T, Landers C, et al. (2009) Genetic epistasis of IL23/IL17 pathway genes in Crohn's disease. Inflamm Bowel Dis 15: 883-9.
50. Tremelling M, Cummings F, Fisher SA, Mansfield J, Gwilliam R, et al. (2007) IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology 132: 1657-64.